hydroxychloroquine and mesalamine

hydroxychloroquine has been researched along with mesalamine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Cotton, P	1
Chu, AD; Deodhar, A; Everding, A; Kim, TH; Kishimoto, M; Maksymowych, WP; Pangan, AL; Sieper, J; Song, IH; Sui, Y; van den Bosch, F; van der Heijde, D; Wang, X	1

Reviews

1 review(s) available for hydroxychloroquine and mesalamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for hydroxychloroquine and mesalamine

Article	Year
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial. Lancet (London, England), 2019, 12-07, Volume: 394, Issue:10214 Topics: Adult; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; Humans; Hydroxychloroquine; Janus Kinase Inhibitors; Magnetic Resonance Imaging; Male; Mesalamine; Methotrexate; Middle Aged; Sacroiliac Joint; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome	2019

Article

Year

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.

Lancet (London, England), 2019, 12-07, Volume: 394, Issue:10214

Topics: Adult; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; Humans; Hydroxychloroquine; Janus Kinase Inhibitors; Magnetic Resonance Imaging; Male; Mesalamine; Methotrexate; Middle Aged; Sacroiliac Joint; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome

2019

Other Studies

2 other study(ies) available for hydroxychloroquine and mesalamine

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
New approaches may aid patients with inflammatory bowel disease. JAMA, 1990, Jun-20, Volume: 263, Issue:23 Topics: Aminosalicylic Acids; Cyclosporins; Fish Oils; Humans; Hydroxychloroquine; Inflammatory Bowel Diseases; Mesalamine; Steroids	1990